Our forthcoming Built Environment Transmission Suppression (BETS) Blueprint explores which nascent technologies show the most promise for reducing indoor pathogen transmission in the built environment.
Far-UVC is an emerging type of germicidal ultraviolet light. It can inactivate a wide range of pathogens with minimal effects on human tissues because it is strongly absorbed by proteins in the outer layer of human skin and eyes. It offers immense promise for continuous disinfection in occupied spaces and improved air cleaning over current alternatives.
We have spent two years interviewing experts across photobiology, atmospheric chemistry, indoor air quality, engineering, epidemiology, and other disciplines. Our Far-UVC Blueprint documents the compelling evidence supporting far-UVC’s safety and efficacy while providing a clear roadmap that identifies high-priority research questions and key building blocks to facilitate widespread adoption.